of implant malposition, but few studies have examined risk factors for malposition and no studies to date have directly compared the use of acellular dermal matrix (ADM) and synthetic mesh for correction of implant malposition. We endeavored to identify risk factors for malposition location and compare outcomes by repair technique.
INTRODUCTION:
Despite the well-established benefits of acellular dermal matrices, a poorly defined entity referred to as red breast syndrome has emerged with an incidence of 1.7-14.3%. It is commonly described as a delayed erythema localized on the skin over the acellular dermal matrix (ADM) appearing days to weeks after reconstructive breast surgery without systemic signs of infection. The aim of our study is to clarify the etiology of this phenomenon. [1] [2] [3] [4] METHODS: Patients presenting with RBS without infectious signs following 1-or 2-stage breast reconstruction with implants using ADMs were recruited prospectively between April 2017 and June 2018 as a case series. All reconstructions consisted of subpectoral prosthesis placement with the ADM acting as an inferolateral hammock. We started broad-spectrum antibiotics, admitted for observation and operated for washout of pocket and implant when no clinical improvement was observed in 24 hours of antibiotic therapy. A control group constituted of asymptomatic patients undergoing 2-stage expander with ADM to permanent implant exchange. During surgery, two 1 cm 2 pieces were collected from the ADMs, one sent for bacterial cultures and the other for scanning electron microscopy. Image analysis of specimens was performed at 3,000× and 6,000× magnifications, including bacterial count and Van Heerden's semiquantitative biofilm scale.
RESULTS:
Study group: 9 breasts in 8 patients presented with red breast syndrome. All 9 ADMs utilized were AlloDerm Ready-to-Use (LifeCell Corporation, N.J.) with a size of 16 × 8 cm. The mean time-to-onset of RBS was 2.5 weeks in 7 patients and 4 years in 1 patient, whereas the mean time from symptoms to surgical exploration was 4 days. Postoperative cultures revealed commonly found bacteria from skin flora and gastrointestinal tract. Furthermore, biofilm from different bacterial populations was found on all samples on scanning electron microscopy pictures. Control group: 8 breasts were reconstructed with Allergan Biocell expanders. The average size was 490 cm 3 , and all procedures were done with submuscular insertion assisted by AlloDerm (16 × 8 cm). Definitive expander-toimplant exchange occurred between 4 and 16 months after the first stage. Specimens from the implant-ADM interface with BACKGROUND: In 1979, Kerrigan et al described the anatomical locations and potential reconstructive use of the different perforating branches of the intercostal artery. Later, in 1986, Holmstrom et al reported a flap based off the lateral perforating branch of the intercostal artery-the lateral intercostal artery perforator (LICAP) flap-as an option for superolateral breast reconstruction. Since that time, the LICAP flap has been described in cases reports, retrospective reviews, and even a prospective trial. However, a review of the literature has yet to be published. The purpose of this study was to review our institution's experience and perform a review of the literature.
METHODS:
A retrospective review was conducted of a single surgeon's experience at a major university center. Patients who underwent LICAP flaps between the years of 2007 and 2018 were included. Pre-and postoperative photographs were reviewed, patient demographics were analyzed, and complication rates were determined. A review of the literature was performed on PubMed with search terms "lateral intercostal artery perforator flap" and "lateral thoracodorsal flap," selecting for articles describing the use of this flap for partial breast reconstruction.
RESULTS:
Eleven total patients underwent lateral perforator flaps for reconstruction of segmental mastectomy. Average age was 55 years old. Diagnosis at the time of breast conserving surgery included ductal carcinoma in situ and invasive carcinoma and chronic wound subsequent to radiation therapy. Total excision volume ranged from 3 × 4 × 2 cm to 6 × 6 × 5 cm, from the superolateral breast. The majority of reconstructions were performed in a delayed fashion. No seromas, no delayed healing, nor any need for operative revision were reported. From our literature search, 137 total articles were initially identified. Of these, 38 included information on 1,453 patients who underwent 1,528 laterally based perforator flaps for partial breast reconstruction. Patient age ranged from 23 to 83 years old, with an average reported specimen weight of 160 g and flap dimensions of 15.7 × 6.9 cm. Overall complication rate was low with most complications classified as minor and not requiring surgical intervention. Major complication leading to surgical revision was seen in only 2.57% of flaps. Donor site complications were not common, with seroma the most frequent seen in 3.5% of cases. Diabetes mellitus, thyroid disease, pulmonary and cardiovascular disorders, flap length over 17 cm, smoking, high body mass index, and history of radiation were significantly associated with complications. Additionally, several studies reported good to excellent esthetic outcomes using verified surveys such as SF-36 and the BREAST-Q, and independent review by other plastic surgeons.
CONCLUSION:
The LICAP flap presents a robust option for reconstruction of superolateral partial mastectomy defects. It may be performed in a delayed fashion to ensure negative margins at the time of reconstruction and achieves good esthetic outcomes with low risk of complications. 
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